Takeyoshi Murano

1.4k total citations
52 papers, 1.2k citations indexed

About

Takeyoshi Murano is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Takeyoshi Murano has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Surgery and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Takeyoshi Murano's work include Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Lipid metabolism and disorders (11 papers) and Lipoproteins and Cardiovascular Health (8 papers). Takeyoshi Murano is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Lipid metabolism and disorders (11 papers) and Lipoproteins and Cardiovascular Health (8 papers). Takeyoshi Murano collaborates with scholars based in Japan, Austria and China. Takeyoshi Murano's co-authors include Yoh Miyashita, Kohji Shirai, Atsuhito Saiki, Hitoshi Watanabe, Masahiro Ohira, Tomokazu Oyama, Kei Endo, Nobukiyo Koide, Takayuki Kawai and Kohji Shirai and has published in prestigious journals such as Nature Communications, Biochemical and Biophysical Research Communications and International Journal of Obesity.

In The Last Decade

Takeyoshi Murano

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeyoshi Murano Japan 24 418 347 334 292 265 52 1.2k
Francesca Urbano Italy 22 407 1.0× 196 0.6× 237 0.7× 234 0.8× 126 0.5× 35 1.0k
Guijun Qin China 24 417 1.0× 175 0.5× 220 0.7× 553 1.9× 212 0.8× 88 1.7k
Minsuk Kim South Korea 18 466 1.1× 371 1.1× 268 0.8× 450 1.5× 147 0.6× 41 1.2k
Yi Pan Canada 18 229 0.5× 457 1.3× 242 0.7× 591 2.0× 392 1.5× 41 1.7k
Tamotsu Yokota Japan 21 315 0.8× 196 0.6× 184 0.6× 589 2.0× 162 0.6× 37 1.4k
Mitchel Tate Australia 17 319 0.8× 350 1.0× 212 0.6× 512 1.8× 119 0.4× 29 1.1k
Saula de Kreutzenberg Italy 17 519 1.2× 350 1.0× 267 0.8× 764 2.6× 302 1.1× 23 1.7k
Michael Basso United States 15 172 0.4× 390 1.1× 283 0.8× 253 0.9× 236 0.9× 23 1.1k
Hiromasa Goto Japan 14 633 1.5× 135 0.4× 231 0.7× 443 1.5× 219 0.8× 35 1.2k
Hisao Wakasaki Japan 16 250 0.6× 593 1.7× 192 0.6× 740 2.5× 246 0.9× 34 1.6k

Countries citing papers authored by Takeyoshi Murano

Since Specialization
Citations

This map shows the geographic impact of Takeyoshi Murano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeyoshi Murano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeyoshi Murano more than expected).

Fields of papers citing papers by Takeyoshi Murano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeyoshi Murano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeyoshi Murano. The network helps show where Takeyoshi Murano may publish in the future.

Co-authorship network of co-authors of Takeyoshi Murano

This figure shows the co-authorship network connecting the top 25 collaborators of Takeyoshi Murano. A scholar is included among the top collaborators of Takeyoshi Murano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeyoshi Murano. Takeyoshi Murano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohira, Masahiro, Yasuhiro Watanabe, Shoko Nakamura, et al.. (2021). Association of Plasma Xanthine Oxidoreductase with Arterial Stiffness in Type 2 Diabetes with Liver Dysfunction. The American Journal of the Medical Sciences. 363(3). 242–250. 5 indexed citations
2.
Ohira, Masahiro, Takashi Yamaguchi, Atsuhito Saiki, et al.. (2019). Laparoscopic Sleeve Gastrectomy Significantly Increases Serum Lipoprotein Lipase Level in Obese Patients. Obesity Facts. 12(3). 357–368. 10 indexed citations
3.
Murano, Takeyoshi, Takehiro Suzuki, Yuki Niwa, et al.. (2017). Regulation of secretion and enzymatic activity of lipoprotein lipase by C -mannosylation. Biochemical and Biophysical Research Communications. 486(2). 558–563. 30 indexed citations
4.
Jiang, Meizi, Wataru Tokuyama, Takeyoshi Murano, et al.. (2016). Levels of soluble LR11/SorLA are highly increased in the bile of patients with biliary tract and pancreatic cancers. Clinica Chimica Acta. 457. 130–136. 16 indexed citations
5.
Murano, Takeyoshi, Takashi Yamaguchi, Ichiro Tatsuno, et al.. (2015). Subfraction analysis of circulating lipoproteins in a patient with Tangier disease due to a novel ABCA1 mutation. Clinica Chimica Acta. 452. 167–172. 6 indexed citations
6.
Komatsu, Haruki, Ayano Inui, Takeyoshi Murano, et al.. (2015). Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice. BMC Research Notes. 8(1). 366–366. 3 indexed citations
7.
Whittle, Andrew J., Meizi Jiang, Vivian Peirce, et al.. (2015). Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nature Communications. 6(1). 8951–8951. 55 indexed citations
8.
Endo, Kei, Atsuhito Saiki, Takashi Yamaguchi, et al.. (2013). Probucol Suppresses Initiation of Chronic Hemodialysis Therapy and Renal Dysfunction-Related Death in Diabetic Nephropathy Patients: Sakura Study. Journal of Atherosclerosis and Thrombosis. 20(5). 494–502. 18 indexed citations
9.
Murano, Takeyoshi, et al.. (2011). Tissue expression of Toll-like receptors 2 and 4 in sporadic human colorectal cancer. Cancer Immunology Immunotherapy. 61(1). 71–77. 44 indexed citations
10.
Saiki, Atsuhito, Masahiro Ohira, Kei Endo, et al.. (2010). Pioglitazone Decreases Plasma Angiotensin II Concentration inType 2 Diabetes. Journal of Atherosclerosis and Thrombosis. 17(6). 651–657. 7 indexed citations
11.
Ohira, Masahiro, Kei Endo, Tomokazu Oyama, et al.. (2010). Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70. Metabolism. 60(1). 78–85. 40 indexed citations
12.
13.
Ohira, Masahiro, Yoh Miyashita, Atsuhito Saiki, et al.. (2007). Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients. Diabetes Research and Clinical Practice. 78(1). 34–41. 28 indexed citations
14.
Saiki, Atsuhito, Masahiro Ohira, Kei Endo, et al.. (2006). The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension. Diabetes Research and Clinical Practice. 74(3). 242–248. 14 indexed citations
15.
Saiki, Atsuhito, et al.. (2005). Pitavastatin Enhanced Lipoprotein Lipase Expression in 3T3-L1 Preadipocytes. Journal of Atherosclerosis and Thrombosis. 12(3). 163–168. 37 indexed citations
16.
Murano, Takeyoshi, T. Sako, Shin Oikawa, & Keiko Shirai. (2005). The recovery of dysfunctional lipoprotein lipase (Asp204-Glu) activity by modification of substrate. Atherosclerosis. 183(1). 101–107. 6 indexed citations
17.
Nagasaka, Hironori, H. Kikuta, Hitoshi Chiba, et al.. (2003). Two cases with transient lipoprotein lipase (LPL) activity impairment: evidence for the possible involvement of an LPL inhibitor. European Journal of Pediatrics. 162(3). 132–138. 8 indexed citations
18.
Miyashita, Yoh, et al.. (2000). Enhancement of preheparin serum lipoprotein lipase mass by bezafbirate administration. Atherosclerosis. 153(1). 175–179. 37 indexed citations
19.
Shirai, Kohji, et al.. (1999). The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serum. Diabetes Research and Clinical Practice. 46(1). 35–41. 61 indexed citations
20.
Murano, Takeyoshi, et al.. (1998). Incidence of lipoprotein lipase genotype for premature termination codon (Ser447-Ter) in Japanese, and association with dyslipoproteinemia. Clinica Chimica Acta. 275(2). 205–213. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Urbano Breakdown of academic impact, for papers by Guijun Qin Breakdown of academic impact, for papers by Minsuk Kim Breakdown of academic impact, for papers by Yi Pan Breakdown of academic impact, for papers by Tamotsu Yokota Breakdown of academic impact, for papers by Mitchel Tate Breakdown of academic impact, for papers by Saula de Kreutzenberg Breakdown of academic impact, for papers by Michael Basso Breakdown of academic impact, for papers by Hiromasa Goto Breakdown of academic impact, for papers by Hisao Wakasaki
Rankless by CCL
2026